A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis
Clinical trial NCT07121413 · RECRUITING
Trial details
- NCT number
- NCT07121413
- Sponsor
- Shanghai Synvida Biotechnology Co.,Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-04
- Primary completion
- 2026-12-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.